← Back to Search

N/A

Healthy control for Arteritis

N/A

Waitlist Available

Led By Holly R Middlekauff, MD

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up intraoperative

Awards & highlights

Study Summary

This trial will compare the effects of smoking cigarettes and using electronic cigarettes on arterial inflammation.

Eligible Conditions

Arteritis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ intraoperative

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~intraoperative

This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

target-to-background ratio (TBR)

Trial Design

3Treatment groups

Experimental Treatment

Group I: Tobacco cigarette smokerExperimental Treatment1 Intervention

Will undergo PET scan as a "positive control"

Group II: Healthy controlExperimental Treatment1 Intervention

Will undergo PET scan as a "negative control"

Group III: E-cigarette userExperimental Treatment1 Intervention

Will undergo PET scan

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,529 Previous Clinical Trials

10,277,772 Total Patients Enrolled

1 Trials studying Arteritis

Holly R Middlekauff, MD4.04 ReviewsPrincipal Investigator - University of California, Los Angeles

University of California, Los Angeles

1 Previous Clinical Trials

200 Total Patients Enrolled

5Patient Review

Dr. Middlekauff is an excellent physician who is easy to communicate with and very knowledgeable. She is highly regarded by both her patients and colleagues. I would not hesitate to recommend her to others.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project accepting elderly participants?

"As per the guidelines for this medical trial, potential participants must be no older than 45 years of age and at least 21."

Answered by AI

What are the requirements for joining this clinical research program?

"To be eligible for this clinical trial, patients must possess arterial inflammation and have a chronological age between 21 and 45. Only 30 participants may partake in the study."

Answered by AI

Is this research trial still recruiting participants?

"This clinical trial, which was initially posted in July 2015 and most recently edited on September 6th 2022, is no longer accepting participants. However, if you're looking for a medical study to enroll in there are currently 377 other trials with open recruitment periods."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Arterial Inflammation and E-Cigarettes

Holly R Middlekauff 2015. "Arterial Inflammation and E-Cigarettes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02734888.